Rivaban 10 Tablet

About Rivaban 10 Tablet

Rivaban 10 is a 10 mg tablet containing rivaroxaban, an oral anti-coagulant that helps reduce the risk of harmful blood clots. It is prescribed by doctors for specific heart and blood vessel conditions.

There are 19 brands of Rivaroxaban listed in Bangladesh. The lowest listed price is Rivadel 2.5 Tablet at ৳ 5 per unit.

What is Rivaban 10 Tablet?

Rivaban 10 is a tablet form of rivaroxaban, made by Advanced Chemical Industries PLC and classed as an oral anti-coagulant. Rivaroxaban works by blocking factor Xa, a substance in the blood clotting process, which reduces the formation of thrombin and helps make clots less likely. Anti-coagulants such as this are used in conditions where the risk of unwanted clots is a concern. Because it affects clotting, bleeding is the main risk to be aware of. The dose and length of treatment are set by the doctor for each person. Ask your doctor or pharmacist if you are unsure why it has been prescribed for you.

Uses of Rivaban 10

Rivaban 10 is used to reduce the risk of stroke and systemic embolism in people with nonvalvular atrial fibrillation, a type of irregular heartbeat. Rivaroxaban products are also used in some other clot-related conditions, such as prevention of atherothrombotic events after acute coronary syndrome and treatment of deep vein thrombosis and pulmonary embolism. Your doctor will explain which of these applies to your situation. Do not start or stop treatment on your own.

How to use Rivaban 10

Take Rivaban 10 exactly as your doctor tells you. The doctor decides the dose, how often to take it and how long the course lasts. Some rivaroxaban products are taken with food or with the evening meal, so follow the instructions given to you. Swallow the tablet as directed. Do not stop taking it without medical advice, since stopping suddenly can raise the risk of clots. If you miss a dose, ask your doctor or pharmacist what to do rather than doubling up.

Side effects of Rivaban 10

The most common side effect of rivaroxaban is a greater chance of bleeding, which may appear as bruising, nosebleeds or bleeding gums, or bleeding that is hard to stop. Spinal or epidural haematoma can occur, particularly with spinal procedures. In people with nonvalvular atrial fibrillation, stopping the medicine raises the risk of stroke. Call your doctor promptly if you notice unusual or prolonged bleeding, or any sign of neurological problems such as weakness or numbness.

Safety and precautions

Tell your doctor before starting Rivaban 10 if you have a bleeding disorder, uncontrolled severe high blood pressure, stomach or bowel disease, vascular retinopathy, bronchiectasis or a history of lung bleeding, as these can raise the risk of serious bleeding. It must not be used if you are allergic to rivaroxaban or have active pathological bleeding. Do not stop the medicine suddenly without alternative anti-coagulation advice. Rivaroxaban is pregnancy category C, with no adequate studies in pregnant women and no established dosing; it is not known whether it passes into breast milk, and safety in breastfeeding has not been established. Pregnant or breastfeeding women should speak to their doctor first.

Frequently asked questions

What side effects should I watch for, and when should I call the doctor?

Watch for unusual bleeding, such as bruising, nosebleeds, bleeding gums or cuts that will not stop, and for signs of nerve problems like weakness or numbness. Call your doctor promptly if any of these occur, or if bleeding is heavy or prolonged.

What is Rivaban 10 used for, and what kind of medicine is it?

Rivaban 10 is an oral anti-coagulant containing rivaroxaban 10 mg. It helps reduce the risk of harmful blood clots. Rivaroxaban products are used for conditions such as nonvalvular atrial fibrillation, and your doctor will explain your specific reason for taking it.

Is Rivaban 10 safe in pregnancy or breastfeeding?

Rivaroxaban is a pregnancy category C drug, and dosing for pregnant women has not been established. It is not known whether it passes into breast milk, and safety in breastfeeding has not been established. Talk to your doctor before using it if you are pregnant or breastfeeding.

Can I stop taking Rivaban 10 on my own?

No. Stopping rivaroxaban early without adequate alternative anti-coagulation can increase the risk of clots, and in nonvalvular atrial fibrillation it raises the risk of stroke. Always ask your doctor before stopping or changing treatment.

Indications

Rivaroxaban 2.5 mg:
  • For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
Rivaroxaban 10-20 mg ... Read moreRivaroxaban 2.5 mg:
  • For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
Rivaroxaban 10-20 mg:
  • To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
  • Deep vein thrombosis (DVT) & pulmonary embolism (PE) and reduction in the risk of recurrence of DVT and of PE
  • For the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery

Pharmacology

Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.

Dosage & Administration

Rivaroxaban 2.5 mg:
  • The recommended dose: 2.5 mg twice daily. Patients should also take a daily dose of 75-100 mg Aspirin or a daily dose of 75-100 mg Aspirin in addition to either a daily dose of 75 mg clopidogrel or a standard daily dose of ticlopidine.
Rivaroxaban 10-20 mg:
  • Nonvalvular Atrial Fibrillation: For patients with Creatinin Clearance >50 mL/min: 20 mg orally, once daily with the evening meal. For patients with Creatinin Clearance 15-50 ml/min: 15 mg orally, once daily with the evening meal.
  • Treatment of DVT & PE: 15 mg orally twice daily with food for the first 21 days for the initial treatment of acute DVT or PE. After the initial treatment period, 20 mg orally once daily with food for the remaining treatment.
  • Prevention in the risk of recurrence of DVT and of PE: 20 mg once daily with food.
  • Prophylaxis of DVT following Hip replacement surgery: 10 mg once daily for 35 days.
  • Prophylaxis of DVT following knee replacement surgery: 10 mg once daily for 12 days.
May be taken with or without food.

Interaction

Concomitant use with drugs that are combined P-gp and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil, dronedarone) increases in Rivaroxaban exposure and pharmacodynamic effects (i.e., factor Xa inhibition and PT prolongation), that’s why should be avoided. Co-administration of Rivaroxaban with a combined P-gp and strong CYP3A4 inducer (e.g., rifampicin, phenytoin, carbamazepine) decreases the efficacy of Rivaroxaban and also should be avoided. The concomitant use of other drugs like anti-platelet agents, heparin, fibrinolytic therapy, NSAIDs may cause an increased risk of bleeding.

Contraindications

It is contraindicated in patients with known hypersensitivity of Rivaroxaban or any of the excipients of the product. It is also contraindicated in patients with active pathological bleeding.

Side Effects

The most common side effects of Rivaroxaban have increased chance of bleeding, spinal or epidural hematoma and increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.

Pregnancy & Lactation

Rivaroxaban is a pregnancy category C drug. There are no adequate or well-controlled studies of Rivaroxaban in pregnant women, and dosing for pregnant women has not been established. It is not known if Rivaroxaban is excreted in human milk. The safety and efficacy of Rivaroxaban has not been established in breastfeeding women.

Precautions & Warnings

Early discontinuation of Rivaroxaban, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. Rivaroxaban increases the risk of bleeding that can be fatal in presence of following risk factors- bleeding disorders, uncontrolled severe arterial hypertension, gastrointestinal disease (e.g., inflammatory bowel disease, oesophagitis, gastritis and gastroesophageal reflux disease), vascular retinopathy, bronchiectasis, history of pulmonary bleeding. Signs or symptoms of neurological impairment should be monitored in case of neuraxial anesthesia (spinal/epidural anesthesia) or spinal puncture as epidural or spinal hematoma can occur. Rivaroxaban is not recommended in patients with pulmonary embolism who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy.

Overdose Effects

Overdose of Rivaroxaban may lead to hemorrhage. Rivaroxaban systemic exposure is not further increased at single doses >50 mg due to limited absorption. A specific antidote for Rivaroxaban is not available. The use of activated charcoal to reduce absorption in case of Rivaroxaban overdose may be considered. Partial reversal of laboratory anticoagulation parameters may be achieved with use of plasma products.

Storage Conditions

Store in a cool (below 30°C) & dry place protected from light. Keep away from the reach of children.

Alternative brands of Rivaroxaban

Other brands with the same generic name, cheapest first.

See all 19 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.